Most Advanced Technology

 
Cordlife Phils. Inc. is the FIRST to bring your family Sepax® 2 – the Standard in Cord Blood Banking.

Stem cell isolation is a critical step in cord blood banking. It affects the number of stem cells that can be harvested or recovered from the cord blood. Cell recovery rates are critical because a higher number of stem cells could enhance the success of the transplant or treatment.
That's why Cordlife upgraded from processing cord blood manually to using a fully automated cord blood processing technology to help you maximize your investment. Cordlife is the FIRST cord blood bank in Philippines to offer the world's most preferred fully automated cord blood processing technology, known as Sepax® 2.

Sepax® 2 is a Swiss-made and U.S. FDA-cleared device offers safe and sterile technology to recover as high as 99.46%* of stem cells* from cord blood. The system is functionally closed which ensures the sterility of the cord blood by eliminating exposure to air contaminants.

Cordlife is the FIRST private cord blood bank in the Philippines to bring you Sepax® 2!

Sepax®2 is a Swiss-made automated processing technology and U.S. FDA-cleared device that can recover as high as 99.46%1 of Total Nucleated Cells (TNC) from cord blood.

Features of Sepax® 2 and what it means to You, as a Parent

Feature

Benefits to You

    Swiss Quality

  • Swiss-made patented automated cord blood processing system
  • Advanced technology with new protocols
  • We process your baby's cord blood with high Swiss precision, reliable, state-of-the-art technology.
    Fully Automated
  • Requires no external centrifuge or operator intervention during processing
  • Controlled, smooth and precise cell separation by an advanced optical sensor.
  • The yield from cord blood processing is consistent, with reproducible high results (that is, cell recoveries).
    Cell Recovery
  • Able to achieve as high as 99.46%1 Total Nucleated Cells (TNC) recovery rate
  • More cells are recovered / harvested from your baby's cord blood for future treatment (if needed), allowing better chance of a successful transplant.
    Safety
  • Closed processing system
  • Each processing step is fully monitored and traceable throughout the procedure.
  • Possesses a troubleshooting system. Even in cases of power failure, all cord blood units can be processed without having errors.
  • The only cord blood processing technology that processes one cord blood unit at a time.
  • Conducts automated kit test before the start of procedure and pressure test to check for any leakage.
  • It optimizes the the sedimentation parameter for each cord blood unit.
  • Processing of your baby's cord blood unit is safe and highly sterile, leaving zero opportunity for error.
  • Prevent any sample mix-up and eliminates any possible cross-contamination of your baby's precious cord blood unit.

    Regulatory Approvals

  • Cleared by U.S. FDA, approved by European Union (evidenced by CE Mark), and Japan MHLW (Ministry of Health and Labor Welfare)
  • Complies with the highest quality standards such as AABB & FACT-Netcord3
  • Meets international health, safety and environmental requirements to ensure consumer safety.

    Statistics/Evidence

  • An advanced cord blood processing technology with proven transplant track record
  • World's most tried and trusted automated system
  • Over 1 million cord blood units3 have been processsed by the Sepax® System in over 50 countries, this is almost half of the worldwide processsing procedures for cord blood inventory.
  • Trusted by majority of the world's leading public and private cord blood banks
  • The Sepax® system has been chosen by over 75% of the Netcord organizations that group the leading public cord blood banks around the world.
  • Proven technology, equipment and consumables that are used by industry leader  - the true validation on the quality of the Sepax® automated processing technology.

    First in the Philippines

  • Cordlife is the first private cord blood bank in Philippines to offer automated cord blood processing with Sepax®2.
  • Our investment in advance technology now and in the future means you and your family will benefit from any future technology upgrade for the long-term storage of your baby's stem cells

References
1 Cordlife umbilical cord blood processing data as at 30 April 2013
2 Total Nucleated Cells

Sources: www.processedbysepax.com and Biosafe, manufacturer of Sepax® (figures accurate as of 17 November 2008).